JP2013510577A5 - - Google Patents

Download PDF

Info

Publication number
JP2013510577A5
JP2013510577A5 JP2012538970A JP2012538970A JP2013510577A5 JP 2013510577 A5 JP2013510577 A5 JP 2013510577A5 JP 2012538970 A JP2012538970 A JP 2012538970A JP 2012538970 A JP2012538970 A JP 2012538970A JP 2013510577 A5 JP2013510577 A5 JP 2013510577A5
Authority
JP
Japan
Prior art keywords
cells
spore
tissue
isolated
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2012538970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013510577A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/056340 external-priority patent/WO2011060135A1/en
Publication of JP2013510577A publication Critical patent/JP2013510577A/ja
Publication of JP2013510577A5 publication Critical patent/JP2013510577A5/ja
Withdrawn legal-status Critical Current

Links

JP2012538970A 2009-11-12 2010-11-11 胞子様細胞の亜集団およびその用途 Withdrawn JP2013510577A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26060709P 2009-11-12 2009-11-12
US61/260,607 2009-11-12
PCT/US2010/056340 WO2011060135A1 (en) 2009-11-12 2010-11-11 Subpopulations of spore-like cells and uses thereof

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2015086621A Division JP2015130887A (ja) 2009-11-12 2015-04-21 胞子様細胞の亜集団およびその用途
JP2017071161A Division JP2017113037A (ja) 2009-11-12 2017-03-31 胞子様細胞の亜集団およびその用途

Publications (2)

Publication Number Publication Date
JP2013510577A JP2013510577A (ja) 2013-03-28
JP2013510577A5 true JP2013510577A5 (enExample) 2013-12-26

Family

ID=43478214

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2012538970A Withdrawn JP2013510577A (ja) 2009-11-12 2010-11-11 胞子様細胞の亜集団およびその用途
JP2015086621A Pending JP2015130887A (ja) 2009-11-12 2015-04-21 胞子様細胞の亜集団およびその用途
JP2017071161A Withdrawn JP2017113037A (ja) 2009-11-12 2017-03-31 胞子様細胞の亜集団およびその用途
JP2018102188A Pending JP2018126171A (ja) 2009-11-12 2018-05-29 胞子様細胞の亜集団およびその用途
JP2018221096A Pending JP2019030336A (ja) 2009-11-12 2018-11-27 胞子様細胞の亜集団およびその用途

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2015086621A Pending JP2015130887A (ja) 2009-11-12 2015-04-21 胞子様細胞の亜集団およびその用途
JP2017071161A Withdrawn JP2017113037A (ja) 2009-11-12 2017-03-31 胞子様細胞の亜集団およびその用途
JP2018102188A Pending JP2018126171A (ja) 2009-11-12 2018-05-29 胞子様細胞の亜集団およびその用途
JP2018221096A Pending JP2019030336A (ja) 2009-11-12 2018-11-27 胞子様細胞の亜集団およびその用途

Country Status (11)

Country Link
US (5) US8551775B2 (enExample)
EP (1) EP2499240A1 (enExample)
JP (5) JP2013510577A (enExample)
KR (3) KR102173873B1 (enExample)
CN (2) CN102762720B (enExample)
AU (4) AU2010319502B2 (enExample)
BR (1) BR112012011183A2 (enExample)
CA (1) CA2780549C (enExample)
IL (4) IL219702A (enExample)
IN (1) IN2012DN05181A (enExample)
WO (1) WO2011060135A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010319502B2 (en) * 2009-11-12 2014-06-12 Vcell Therapeutics, Inc. Subpopulations of spore-like cells and uses thereof
WO2013011131A2 (en) * 2011-07-20 2013-01-24 Angewandte Biotechnologie Gmbh Pluripotent tendon and ligament perivascular cells
KR101495281B1 (ko) * 2014-01-10 2015-02-24 (주)안트로젠 피부 재생 또는 상처 치유를 위한 중간엽 줄기세포-하이드로겔-생분해성 또는 중간엽 줄기세포-하이드로겔-비분해성 지지체 조성물
CN113750224B (zh) 2015-05-19 2024-04-30 科学蛋白实验室有限责任公司 在生产胰酶过程中减少或灭活病毒和微生物内容物的方法
EP3371232B1 (en) 2015-11-03 2021-01-06 LORD Corporation Two-parts adhesive system
US11435350B2 (en) * 2018-09-18 2022-09-06 Medeor Therapeutics, Inc. Methods of analysis of blood from deceased donors

Family Cites Families (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060081A (en) 1975-07-15 1977-11-29 Massachusetts Institute Of Technology Multilayer membrane useful as synthetic skin
US4188373A (en) 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
DE2657370C2 (de) 1976-12-17 1982-11-11 Hans Dr.med. Dr.med.dent. 8000 München Scheicher Mittel zum Bedecken und/oder Ausfüllen von Knochendefekten
US4352883A (en) 1979-03-28 1982-10-05 Damon Corporation Encapsulation of biological material
US4419936A (en) 1980-04-11 1983-12-13 The United States Of America As Represented By The Secretary Of The Army Ballistic projectile
US4474753A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Topical drug delivery system utilizing thermosetting gels
US4474752A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4474751A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4478822A (en) 1983-05-16 1984-10-23 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
US4997443A (en) 1985-08-26 1991-03-05 Hana Biologics, Inc. Transplantable artificial tissue and process
US5266480A (en) 1986-04-18 1993-11-30 Advanced Tissue Sciences, Inc. Three-dimensional skin culture system
US5567612A (en) 1986-11-20 1996-10-22 Massachusetts Institute Of Technology Genitourinary cell-matrix structure for implantation into a human and a method of making
US5041138A (en) 1986-11-20 1991-08-20 Massachusetts Institute Of Technology Neomorphogenesis of cartilage in vivo from cell culture
US5736372A (en) 1986-11-20 1998-04-07 Massachusetts Institute Of Technology Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
CA1340581C (en) 1986-11-20 1999-06-08 Joseph P. Vacanti Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
US5804178A (en) 1986-11-20 1998-09-08 Massachusetts Institute Of Technology Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
US4846835A (en) 1987-06-15 1989-07-11 Grande Daniel A Technique for healing lesions in cartilage
US5786216A (en) 1987-11-17 1998-07-28 Cytotherapeutics, Inc. Inner-supported, biocompatible cell capsules
US5575815A (en) 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
IL90690A0 (en) 1988-09-30 1990-01-18 Organogenesis Inc Tissue equivalents and their preparation
US5126141A (en) 1988-11-16 1992-06-30 Mediventures Incorporated Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
US5082670A (en) 1988-12-15 1992-01-21 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage or the central nervous system
US5650148A (en) 1988-12-15 1997-07-22 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
WO1991001720A1 (en) 1989-08-07 1991-02-21 Herman Wade Schlameus Composition and method of promoting hard tissue healing
US5411883A (en) 1989-12-26 1995-05-02 Somatix Therapy Corporation Proliferated neuron progenitor cell product and process
US5292655A (en) 1990-01-29 1994-03-08 Wille Jr John J Method for the formation of a histologically-complete skin substitute
US5061620A (en) 1990-03-30 1991-10-29 Systemix, Inc. Human hematopoietic stem cell
US5300295A (en) 1990-05-01 1994-04-05 Mediventures, Inc. Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH
US5306501A (en) 1990-05-01 1994-04-26 Mediventures, Inc. Drug delivery by injection with thermoreversible gels containing polyoxyalkylene copolymers
US5292516A (en) 1990-05-01 1994-03-08 Mediventures, Inc. Body cavity drug delivery with thermoreversible gels containing polyoxyalkylene copolymers
US5298260A (en) 1990-05-01 1994-03-29 Mediventures, Inc. Topical drug delivery with polyoxyalkylene polymer thermoreversible gels adjustable for pH and osmolality
US5077033A (en) 1990-08-07 1991-12-31 Mediventures Inc. Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
US5071644A (en) 1990-08-07 1991-12-10 Mediventures, Inc. Topical drug delivery with thermo-irreversible gels
US5410016A (en) 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
US5529914A (en) 1990-10-15 1996-06-25 The Board Of Regents The Univeristy Of Texas System Gels for encapsulation of biological materials
EP0554352B1 (en) 1990-10-19 2003-03-05 New York University A method for transplanting cells into the brain and therapeutic uses therefor
US5192326A (en) 1990-12-21 1993-03-09 Pfizer Hospital Products Group, Inc. Hydrogel bead intervertebral disc nucleus
CA2082411A1 (en) 1991-06-28 1992-12-29 Robert D. Rosenberg Localized oligonucleotide therapy
US5750376A (en) 1991-07-08 1998-05-12 Neurospheres Holdings Ltd. In vitro growth and proliferation of genetically modified multipotent neural stem cells and their progeny
US5851832A (en) 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
EP0612253A4 (en) 1991-11-12 1995-08-09 Nepera Inc ANKLEBENOK HYDROGELS WITH EXTENDED LIFE AND METHOD FOR THEIR PRODUCTION.
WO1993024627A1 (en) 1992-06-03 1993-12-09 Case Western Reserve University Bandage for continuous application of biologicals
AU4543193A (en) 1992-06-22 1994-01-24 Henry E. Young Scar inhibitory factor and use thereof
US5589376A (en) 1992-07-27 1996-12-31 California Institute Of Technology Mammalian neural crest stem cells
WO1994002593A1 (en) 1992-07-27 1994-02-03 California Institute Of Technology Mammalian multipotent neural stem cells
US5514379A (en) 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
US5766948A (en) 1993-01-06 1998-06-16 The Regents Of The University Of California Method for production of neuroblasts
US5512600A (en) 1993-01-15 1996-04-30 Massachusetts Institute Of Technology Preparation of bonded fiber structures for cell implantation
US5514378A (en) 1993-02-01 1996-05-07 Massachusetts Institute Of Technology Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
DE4431598C2 (de) 1993-03-03 1997-03-20 Michael Sittinger Verfahren zum Herstellen eines Implantates aus Zellkulturen
DE4306661C2 (de) 1993-03-03 1995-04-20 Michael Dipl Biol Sittinger Verfahren zum Herstellen eines Implantates aus Zellkulturen
WO1994025079A1 (en) 1993-04-23 1994-11-10 Massachusetts Institute Of Technology Porous biodegradable polymeric materials for cell transplantation
US5709854A (en) 1993-04-30 1998-01-20 Massachusetts Institute Of Technology Tissue formation by injecting a cell-polymeric solution that gels in vivo
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
US5853717A (en) 1994-07-20 1998-12-29 Cytotherapeutics, Inc. Methods and compositions of growth control for cells encapsulated within bioartificial organs
US5834029A (en) 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
US5827742A (en) 1994-09-01 1998-10-27 Beth Israel Deaconess Medical Center, Inc. Method of selecting pluripotent hematopioetic progenitor cells
WO1996015226A1 (en) 1994-11-14 1996-05-23 Neurospheres Holdings Ltd. Regulation of neural stem cell proliferation
US5716404A (en) 1994-12-16 1998-02-10 Massachusetts Institute Of Technology Breast tissue engineering
US5736396A (en) 1995-01-24 1998-04-07 Case Western Reserve University Lineage-directed induction of human mesenchymal stem cell differentiation
US5855610A (en) 1995-05-19 1999-01-05 Children's Medical Center Corporation Engineering of strong, pliable tissues
US5830651A (en) 1995-06-01 1998-11-03 Signal Pharmaceuticals, Inc. Human oligodendroglial progenitor cell line
US5800811A (en) 1995-06-06 1998-09-01 Hall; Frederick L. Artificial skin prepared from coclagen matrix containing transforming growth factor-β having a collagen binding site
US6129761A (en) 1995-06-07 2000-10-10 Reprogenesis, Inc. Injectable hydrogel compositions
US5780300A (en) 1995-09-29 1998-07-14 Yale University Manipulation of non-terminally differentiated cells using the notch pathway
EP0801676A2 (de) 1995-10-20 1997-10-22 Michael Sittinger Neue künstliche gewebe, verfahren zu ihrer herstellung und ihre verwendung
WO1997017038A1 (en) 1995-11-09 1997-05-15 University Of Massachusetts Tissue re-surfacing with hydrogel-cell compositions
CA2251983C (en) 1996-04-19 2003-12-16 Sudhakar Kadiyala Regeneration and augmentation of bone using mesenchymal stem cells
CA2253724A1 (en) 1996-04-26 1997-11-06 Case Western Reserve University Skin regeneration using mesenchymal stem cells
US5753506A (en) 1996-05-23 1998-05-19 Cns Stem Cell Technology, Inc. Isolation propagation and directed differentiation of stem cells from embryonic and adult central nervous system of mammals
ATE250666T1 (de) 1996-06-04 2003-10-15 Sulzer Orthopedics Ltd Verfahren zur herstellung von knorpelgewebe und von implantaten
US6518236B1 (en) 1996-10-16 2003-02-11 Zymogenetics, Inc. FGF homologs
TW528600B (en) 1996-11-20 2003-04-21 Yasuhiko Shimizu Artificial neural canal
DK0941344T3 (da) 1996-11-27 2004-09-27 Genentech Inc Humaniserede anti-CD11a-antistoffer
EP0965310A4 (en) 1996-12-06 2003-03-19 Tapic Int Co Ltd ARTIFICIAL BLOOD VESSEL
JP3632344B2 (ja) 1997-01-06 2005-03-23 日産自動車株式会社 半導体装置
WO1998030678A1 (en) 1997-01-07 1998-07-16 Steindler Dennis A Isolated mammalian neural stem cells, methods of making such cells, and methods of using such cells
US6027744A (en) 1998-04-24 2000-02-22 University Of Massachusetts Medical Center Guided development and support of hydrogel-cell compositions
CA2395117C (en) * 1999-12-30 2016-03-22 University Of Massachusetts Spore-like cells and uses thereof
US7575921B2 (en) * 1999-12-30 2009-08-18 Vbi Technologies, L.L.C. Spore-like cells and uses thereof
US7560275B2 (en) * 1999-12-30 2009-07-14 Vbi Technologies, L.L.C. Compositions and methods for generating skin
WO2002057428A1 (en) * 2000-10-30 2002-07-25 University Of Massachusetts Isolation of spore-like cells from tissues exposed to extreme conditions
EP2354227B1 (en) * 2001-05-31 2017-04-19 Shinya Yamanaka Genes with ES cell-specific expression
WO2003093426A2 (en) 2002-05-02 2003-11-13 University Of North Carolina At Chapel Hill In vitro mutagenesis, phenotyping, and gene mapping
KR100451409B1 (ko) 2002-10-15 2004-10-06 한국전자통신연구원 마이크로 광스위치 및 그 제조방법
JP2004213087A (ja) 2002-12-26 2004-07-29 Toshiba Corp 個人認証装置および個人認証方法
JP2005151907A (ja) 2003-11-27 2005-06-16 Shigeo Saito 胎盤又は羊膜由来ヒト幹細胞及びその樹立方法並びに臓器への分化誘導方法
US20050186672A1 (en) 2004-01-27 2005-08-25 Reliance Life Sciences Pvt. Ltd. Tissue system with undifferentiated stem cells derived from corneal limbus
US7310147B2 (en) 2005-01-27 2007-12-18 Genetix Limited Robotic apparatus for picking of cells and other applications with integrated spectroscopic capability
ES2325715B1 (es) * 2007-08-03 2010-06-17 Genetrix, S.L. Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca.
JP2009055866A (ja) * 2007-08-31 2009-03-19 Univ Kinki 滑膜組織由来の幹細胞および細胞株ならびにその濃縮培養方法
JP2009195142A (ja) * 2008-02-20 2009-09-03 Institute Of Physical & Chemical Research 肝臓卵形細胞の取得方法
EP2276838A4 (en) 2008-04-07 2012-02-01 Nupotential Inc RE-PROGRAMMING A CELL BY INDUCING A PLURIPOTENTIC GENE THROUGH RNA INTERFERENCE
AU2010319502B2 (en) * 2009-11-12 2014-06-12 Vcell Therapeutics, Inc. Subpopulations of spore-like cells and uses thereof

Similar Documents

Publication Publication Date Title
Suman et al. Potential clinical applications of stem cells in regenerative medicine
Ratajczak et al. A novel view of the adult stem cell compartment from the perspective of a quiescent population of very small embryonic-like stem cells
Nekanti et al. Long-term expansion and pluripotent marker array analysis of Wharton’s jelly-derived mesenchymal stem cells
Mothe et al. Advances in stem cell therapy for spinal cord injury
Li et al. Derivation of murine induced pluripotent stem cells (iPS) and assessment of their differentiation toward osteogenic lineage
Shaikh et al. Mouse bone marrow VSELs exhibit differentiation into three embryonic germ lineages and germ & hematopoietic cells in culture
Wakao et al. M use cells, newly found non‐tumorigenic pluripotent stem cells, reside in human mesenchymal tissues
Lee et al. Maintenance and characterization of multipotent mesenchymal stem cells isolated from canine umbilical cord matrix by collagenase digestion
Hong et al. Ontogeny of human umbilical cord perivascular cells: molecular and fate potential changes during gestation
JP2019517538A5 (enExample)
Lee et al. Sequential sub-passage decreases the differentiation potential of canine adipose-derived mesenchymal stem cells
Ratajczak et al. Stem cells for neural regeneration-a potential application of very small embryonic-like stem cells
Wakao et al. The elite and stochastic model for iPS cell generation: Multilineage‐differentiating stress enduring (Muse) cells are readily reprogrammable into iPS cells
JP2016519939A5 (enExample)
Shi et al. Urine-derived induced pluripotent/neural stem cells for modeling neurological diseases
Nagura et al. Effect of exogenous Oct4 overexpression on cardiomyocyte differentiation of human amniotic mesenchymal cells
Ratajczak et al. A novel insight into aging: are there pluripotent very small embryonic-like stem cells (VSELs) in adult tissues overtime depleted in an Igf-1-dependent manner?
Gericota et al. Canine epidermal neural crest stem cells: characterization and potential as therapy candidate for a large animal model of spinal cord injury
US20200248146A1 (en) Methods for differentiating cells into hepatic stellate cells
Zhang et al. The neural plasticity of early‐passage human bone marrow‐derived mesenchymal stem cells and their modulation with chromatin‐modifying agents
BR112012011183A2 (pt) sub-população isolada de células similares a esporos e método para isolar uma sub-população de células similares a esporos
Du et al. hiPSC-neural stem/progenitor cell transplantation therapy for spinal cord injury
US12529033B2 (en) Method of isolating myogenic progenitors using CD54
Gasiūnienė et al. Epigenetic alterations in amniotic fluid mesenchymal stem cells derived from normal and fetus‐affected gestations: A focus on myogenic and neural differentiations
Arrighi Stem cells: therapeutic innovations under control